Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Vogel

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|January 1, 1984
Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancerG Wang, C L Vogel, S G Hilsenbeck, et al.
Journal of the National Cancer Institute|May 1, 1982
Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levelsD A Cheresh, J A Distasio, C L Vogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancerC L Vogel, J Schoenfelder, I Shemano, et al.
Oncology|January 26, 2002
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trialM Blackstein, C L Vogel, R Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancerC L Vogel, I Shemano, J Schoenfelder, et al.
Cancer Treatment Reports|September 1, 1986
Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group TrialJ T Carpenter, R V Smalley, M Raney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancerE A Perez, C L Vogel, D H Irwin, et al.
Cancer|February 1, 1976
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinomaK R McIntire, C L Vogel, A Primack, et al.
British Medical Journal|February 12, 1972
Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathologyP P Anthony, C L Vogel, F Sadikali, et al.
Cancer|May 1, 1977
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesC L Vogel, A C Bayley, R J Brooker, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|January 1, 1984
Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancerG Wang, C L Vogel, S G Hilsenbeck, et al.
Journal of the National Cancer Institute|May 1, 1982
Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levelsD A Cheresh, J A Distasio, C L Vogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancerC L Vogel, J Schoenfelder, I Shemano, et al.
Oncology|January 26, 2002
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trialM Blackstein, C L Vogel, R Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancerC L Vogel, I Shemano, J Schoenfelder, et al.
Cancer Treatment Reports|September 1, 1986
Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group TrialJ T Carpenter, R V Smalley, M Raney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancerE A Perez, C L Vogel, D H Irwin, et al.
Cancer|February 1, 1976
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinomaK R McIntire, C L Vogel, A Primack, et al.
British Medical Journal|February 12, 1972
Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathologyP P Anthony, C L Vogel, F Sadikali, et al.
Cancer|May 1, 1977
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesC L Vogel, A C Bayley, R J Brooker, et al.
Pageof 6